表紙
市場調查報告書

全球免疫組織化學(IHC)市場(∼2025):抗體/試劑/試劑盒

Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 954045
出版日期 內容資訊 英文 226 Pages
訂單完成後即時交付
價格
全球免疫組織化學(IHC)市場(∼2025):抗體/試劑/試劑盒 Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025
出版日期: 2020年08月10日內容資訊: 英文 226 Pages
簡介

全球免疫組化(IHC)市場預計將在預測期內以6.6%的複合年增長率增長,從2020年的19億美元增長到2025年的27億美元。諸如癌症的發生率和患病率增加,IHC的技術進步以及IHC測試報銷的可用性等因素正在推動市場的增長。另一方面,高度的整合將阻礙市場的進一步增長。按一抗的類型,一抗的發展迅速。推動該領域增長的因素包括更高的治療性抗體監管批准率,針對性免疫療法的採用增加以及製藥和生物技術公司的研發成本更高。按設備類型劃分,載玻片染色系統領域所佔份額最大。高通量染色系統的發展正在推動該部門的發展。

本報告調查了全球免疫組織化學(IHC)市場,定義和概述了該市場,分析了COVID-19和其他市場影響因素,市場規模趨勢和預測,產品類別和應用。匯總了最終用戶,地區/主要國家,競爭環境,主要公司的概況等各種類別的細分。

第1章簡介

第2章調查方法

第3章執行摘要

第4章重要注意事項

第5章市場概述

  • 市場動態
    • 促進要因
    • 抑制因子
    • 市場機會
    • 挑戰
  • COVID-19的影響

第6章按產品進行的市場分析和預測

  • 抗體
    • 一級抗體
    • 二級抗體
  • 試劑
    • 組織染色
    • 阻斷血清/試劑
    • 髮色底物
    • 定影劑
    • 有機溶劑
    • 稀釋劑
    • 蛋白水解□
    • 其他
  • 設備
    • 幻燈片染色系統
    • 組織處理系統
    • 幻燈片掃瞄儀
    • 其他
  • 套件
    • 人類免疫組化試劑盒
    • 動物免疫組化試劑盒

第7章按應用進行市場分析和預測

  • 診斷
    • 癌症
    • 傳染病
    • 腎臟疾病
    • 自身免疫性疾病
    • 神經系統疾病
    • 其他
  • 研究
    • 藥物開發和測試
    • 其他
  • 法醫學

第8章最終用戶的市場分析和預測

  • 醫院/診斷實驗室
  • 學術研究所
  • 其他

第9章按地區和主要國家進行的市場分析和預測

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區
    • 拉丁美洲
    • 中東/非洲

第10章競爭情況

  • 市場排名分析
  • 市場評估框架
  • 競爭場景

第11章企業評估矩陣和企業概況

  • 概述
  • 公司評估表
  • 公司簡介
    • F. HOFFMANN-LA ROCHE AG
    • DANAHER CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • MERCK KGAA
    • BIO-RAD LABORATORIES, INC.
    • PHC HOLDINGS CORPORATION
    • BIO-TECHNE CORPORATION
    • ABCAM PLC
    • BECTON, DICKINSON AND COMPANY
    • PERKINELMER
    • CELL SIGNALING TECHNOLOGY, INC.
    • BIO SB, INC.
    • MILTENYI BIOTEC
    • CANDOR BIOSCIENCE GMBH
    • SAKURA FINETEK JAPAN CO., LTD.
    • EAGLEBIO
    • BIOCARE MEDICAL, LLC
    • ELABSCIENCE, INC.
    • BIOGENEX
    • DIAGNOSTIC BIOSYSTEMS

第12章附錄

目錄
Product Code: BT 4780

"Increasing incidence of chronic diseases, and technological advancements in IHC are set to drive the IHC market."

The global immunohistochemistry market is projected to reach USD 2.7 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 6.6% during the forecast period. The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the growth of this market. However, the high degree of consolidation is expected to restrain the growth of this market during the forecast period

"By antibodies type, the primary antibodies accounted for the fasted growing antibody segment of the IHC market"

The antibodies segment includes primary antibodies and secondary antibodies. The primary antibodies segment accounted for the fastest growing IHC antibodymarket. Factors such as improved approval rate for therapeutic antibodies by regulatory authorities, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies. Also, the mandatory use of primary antibodies in IHC protocols and their extensive application in diverse diagnostic and research areas have resulted in continuous demand for these antibodies.

"By equipment type, the slide-staining systems segment accounted for the largest share of the IHC equipement market"

Based on equipment type, the IHC equipment segment is further divided into slide-staining systems, tissue processing systems, slide scanners, and other equipment (automated cover slippers, microtomes, paraffin dispensers, tissue microarrays, and slide labelers). The slide-staining systems accounted for the largest share of IHC market, by equipment. Development of high-throughput staining systems is one of the major factor driving market growth.

"Asia Pacific: The fastest-growing region in the IHC market."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the large population in emerging economies such as China, India, and Japan; rising prevalence of chronic diseases; rising demand for quality medical care; and the increasing healthcare spending are expected to boost the IHC market in the Asia Pacific.

"North America: the largest share of the IHC market"

North America accounted for the largest share of the IHC market. The large share of this segment can primarily be attributed to the to the presence of major players operating in the IHC market in the US, rising incidence of cancer and infectious diseases, and the increasing adoption of companion diagnostic assay kits.

Breakdown of Primaries:

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.

The break-up of the primaries is as follows:

  • By Respondent - Supply Side- 80%, Demand Side-20%
  • By Designation - Executives- 25%, CXOs- 20%, Managers - 55%
  • By Region - North America - 50%, Europe - 20%, APAC - 20%, RoW- 10%

The IHC market is dominated by a few globally established players such as F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc (UK), Becton, Dickinson and Company (US), Histo-Line Laboratories (Italy), Bio SB, Inc. (US), Diagnostic BioSystems (US), BioGenex (US), Bio-Rad Laboratories, Inc. (US), Biocare Medical, LLC. (US), Miltenyi Biotec (US), CANDOR Bioscience GmbH (Germany), EagleBio (US), Cell Signaling Technology, Inc. (US), Enzo Biochem Inc. (US), BioVision, Inc. (US), Elabscience, Inc. (China), Amos Scientific Pty Ltd. (Australia), Bio-Techne (US), and Jinhua YIDI Medical Appliance CO., LTD. (China)

Research Coverage:

The report segments the IHC market based on region (Asia Pacific, Europe, North America, and RoW), product (antibodies, equipment, kits, and reagents), application (diagnostics, research, and forensic), and end user (hospitals & diagnostic laboratories, academic & research institutes, and other end users).

The report also provides a comprehensive review of market drivers, restraints, challenges, and opportunities in the IHC market

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the IHC market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 1 BREAKDOWN OF PRIMARIES: IMMUNOHISTOCHEMISTRY MARKET
    • 2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
    • 2.1.4 DATA TRIANGULATION
    • FIGURE 2 DATA TRIANGULATION METHODOLOGY
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • FIGURE 4 IMMUNOHISTOCHEMISTRY MARKET SIZE (USD BILLION)
    • FIGURE 5 IMMUNOHISTOCHEMISTRY MARKET: FINAL CAGR PROJECTIONS (2020-2025)
    • FIGURE 6 IMMUNOHISTOCHEMISTRY MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
  • 2.3 INDUSTRY INSIGHTS
  • 2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 IMMUNOHISTOCHEMISTRY MARKET SHARE, BY APPLICATION, 2019
    • FIGURE 9 IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2020-2025
    • FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE IMMUNOHISTOCHEMISTRY MARKET

4 PREMIUM INSIGHTS

  • 4.1 IMMUNOHISTOCHEMISTRY MARKET OVERVIEW
    • FIGURE 11 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SHARE, BY END USER AND COUNTRY (2019)
    • FIGURE 12 HOSPITALS & DIAGNOSTIC LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC IHC MARKET IN 2019
  • 4.3 IMMUNOHISTOCHEMISTRY ANTIBODIES MARKET, BY TYPE
    • FIGURE 13 PRIMARY ANTIBODIES SEGMENT WILL CONTINUE TO DOMINATE THE IHC ANTIBODIES MARKET IN THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 14 IMMUNOHISTOCHEMISTRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing incidence and prevalence of cancer
    • FIGURE 15 CANCER INCIDENCE, BY REGION AND TYPE OF CANCER, 2018
      • 5.2.1.2 Technological advancements in IHC
      • 5.2.1.3 Availability of reimbursements for IHC tests
    • TABLE 1 CPT CODES FOR IHC PROCEDURES
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High degree of consolidation
    • TABLE 2 MAJOR ACQUISITIONS IN THE MARKET, 2015-2020
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing demand for personalized medicine
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals
    • TABLE 3 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
      • 5.2.4.2 Product failures and recalls
  • 5.3 IMPACT OF COVID-19 ON THE IMMUNOHISTOCHEMISTRY MARKET

6 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 4 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 6.2 ANTIBODIES
    • TABLE 5 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 6 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 7 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 8 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 9 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 10 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • 6.2.1 PRIMARY ANTIBODIES
      • 6.2.1.1 Wide applications in diagnostics and research to support the demand for primary antibodies
    • TABLE 11 IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 12 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 13 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 14 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 15 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2018-2025 (USD MILLION)
    • 6.2.2 SECONDARY ANTIBODIES
      • 6.2.2.1 Signal amplification through conjugation and comparatively easy manufacturing to drive the market for secondary antibodies
    • TABLE 16 IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 17 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 18 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 19 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 20 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2018-2025 (USD MILLION)
  • 6.3 REAGENTS
    • TABLE 21 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 22 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 23 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 24 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 25 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 26 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2018-2025 (USD MILLION)
    • 6.3.1 HISTOLOGICAL STAINS
      • 6.3.1.1 Developments in tumor detection and cancer disease progression studies to propel market growth
    • TABLE 27 IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.2 BLOCKING SERA AND REAGENTS
      • 6.3.2.1 Blocking sera and reagents prevent the nonspecific binding activity of antibodies
    • TABLE 28 IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.3 CHROMOGENIC SUBSTRATES
      • 6.3.3.1 Chromogenic substrates segment to register the highest growth during the forecast period
    • TABLE 29 IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.4 FIXATION REAGENTS
      • 6.3.4.1 North America is the largest market for fixation reagents
    • TABLE 30 IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.5 ORGANIC SOLVENTS
      • 6.3.5.1 Organic solvents prevent physical damage in specimens and improve clarity while visualizing tissue samples
    • TABLE 31 IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.6 DILUENTS
      • 6.3.6.1 Diluents are used in the preparation of antibody solutions
    • TABLE 32 IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.7 PROTEOLYTIC ENZYMES
      • 6.3.7.1 Proteolytic enzymes improve the accessibility of target antibodies
    • TABLE 33 IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.8 OTHER REAGENTS
      • 6.3.8.1 Other reagents include antigen retrieval solutions, stabilizers, controls, and mounting solutions.
    • TABLE 34 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY REGION, 2018-2025 (USD MILLION)
  • 6.4 EQUIPMENT
    • TABLE 35 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 36 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 37 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 38 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 39 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 40 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • 6.4.1 SLIDE-STAINING SYSTEMS
      • 6.4.1.1 Development of high-throughput staining systems to drive market growth
    • TABLE 41 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 42 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 43 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 44 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 45 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2018-2025 (USD MILLION)
    • 6.4.2 TISSUE PROCESSING SYSTEMS
      • 6.4.2.1 Technological advancements and need for automation due to shortage of staff to drive market growth
    • TABLE 46 IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 47 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 48 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 49 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 50 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2018-2025 (USD MILLION)
    • 6.4.3 SLIDE SCANNERS
      • 6.4.3.1 Development of advanced multiplexed IHC scanners to drive market growth
    • TABLE 51 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 52 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 53 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 54 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 55 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY REGION, 2018-2025 (USD MILLION)
    • 6.4.4 OTHER EQUIPMENT
    • TABLE 56 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 57 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 58 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 59 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 60 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY REGION, 2018-2025 (USD MILLION)
  • 6.5 KITS
    • TABLE 61 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 62 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 63 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 64 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 65 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 66 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY TYPE, 2018-2025 (USD MILLION)
    • 6.5.1 HUMAN IMMUNOHISTOCHEMISTRY KITS
      • 6.5.1.1 Increasing focus on cancer research to fuel market growth
    • 6.5.2 ANIMAL IMMUNOHISTOCHEMISTRY KITS
      • 6.5.2.1 Increasing preclinical drug testing to drive market growth

7 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 67 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 7.2 DIAGNOSTIC APPLICATIONS
    • TABLE 68 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 69 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 70 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 71 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 72 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 73 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2020-2025 (USD MILLION)
    • 7.2.1 CANCER
      • 7.2.1.1 Growing use of IHC tests for cancer diagnostics to fuel the market growth
    • TABLE 74 IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 75 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 76 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 77 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 78 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.2 INFECTIOUS DISEASES
      • 7.2.2.1 Growing prevalence of infectious diseases and rising awareness of early diagnosis to propel market growth
    • TABLE 79 IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 80 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 81 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 82 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 83 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.3 NEPHROLOGICAL DISEASES
      • 7.2.3.1 Wide application of IHC in transplant rejection is expected to support market growth
    • TABLE 84 IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 85 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 86 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 87 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 88 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.4 AUTOIMMUNE DISEASES
      • 7.2.4.1 Availability of numerous primary antibodies and rapid processing of results make IHC a favorable diagnostic approach
    • TABLE 89 IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 90 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 91 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 92 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 93 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.5 NEUROLOGICAL DISEASES
      • 7.2.5.1 Increasing global burden of neurological diseases to propel market growth
    • TABLE 94 IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 95 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 96 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 97 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 98 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • 7.2.6 OTHER DISEASES
    • TABLE 99 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 100 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 101 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 102 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 103 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 RESEARCH APPLICATIONS
    • TABLE 104 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 105 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 106 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 107 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 108 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • 7.3.1 DRUG DEVELOPMENT & TESTING
      • 7.3.1.1 Quantitative image analysis makes IHC techniques ideal for drug testing
    • 7.3.2 OTHER RESEARCH APPLICATIONS
    • TABLE 109 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • 7.4 FORENSIC APPLICATIONS
    • TABLE 110 IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 111 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 112 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 113 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 114 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)

8 IMMUNOHISTOCHEMISTRY MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 115 IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 8.2 HOSPITALS & DIAGNOSTIC LABORATORIES
    • 8.2.1 INCREASING INCIDENCE OF CANCER AND INFECTIOUS DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES
    • TABLE 116 IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 117 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 118 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 119 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 120 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 ACADEMIC & RESEARCH INSTITUTES
    • 8.3.1 INCREASING USE OF IHC TESTS FOR DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO SUPPORT MARKET GROWTH
    • TABLE 121 IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 122 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 123 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 124 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 125 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 126 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 127 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 128 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 129 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 130 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

9 IMMUNOHISTOCHEMISTRY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 131 IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2018-2025 (USD MILLION) 116
  • 9.2 NORTH AMERICA
    • FIGURE 16 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
    • TABLE 132 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 133 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 134 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 135 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 136 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 137 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 138 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 139 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 US is the largest country-level market for immunohistochemistry
    • TABLE 140 US: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 141 US: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 142 US: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 143 US: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 144 US: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 145 US: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Increasing cancer cases in Canada to support market growth
    • TABLE 146 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 147 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 148 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 149 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 150 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 151 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 152 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 153 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 154 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 155 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 156 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 157 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 158 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 159 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany to dominate the European IHC market
    • TABLE 160 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 161 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 162 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 163 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 164 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 165 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Increasing use of IHC in cancer diagnosis and research to drive market growth
    • TABLE 166 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 167 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 168 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 169 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 170 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 171 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Increasing number of cancer research studies to support market growth
    • TABLE 172 UK: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 173 UK: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 174 UK: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 175 UK: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 176 UK: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 177 UK: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 High incidence of cancer to support market growth in Italy
    • TABLE 178 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 179 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 180 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 181 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 182 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 183 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing demand for personalized medicine will drive the demand for IHC tests to find potential biomarkers
    • TABLE 184 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 185 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 186 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 187 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 188 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 189 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 190 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 191 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 192 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 193 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 194 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 195 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • TABLE 196 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • FIGURE 17 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
    • TABLE 197 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 198 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 199 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 200 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 201 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 202 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 203 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan to dominate the Asia Pacific immunohistochemistry market
    • TABLE 204 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 205 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 206 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 207 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 208 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 209 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 China to register the highest growth during the forecast period
    • TABLE 210 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 211 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 212 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 213 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 214 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 215 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 India is a key destination for high-end pathology and diagnostic services
    • TABLE 216 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 217 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 218 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 219 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 220 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 221 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 222 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 223 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 224 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 225 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 226 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 227 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 228 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 229 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 230 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 231 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 232 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 233 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 234 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 235 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.5.1 LATIN AMERICA
      • 9.5.1.1 Increasing incidence of cancer in Latin America is driving market growth
    • TABLE 236 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 237 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 238 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 239 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 240 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 241 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 9.5.2 MIDDLE EAST AND AFRICA
      • 9.5.2.1 Government initiatives focused on boosting healthcare infrastructure development to drive market growth
    • TABLE 242 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 243 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 244 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 245 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 246 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2018-2025 (USD MILLION)
    • TABLE 247 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET RANKING ANALYSIS
    • FIGURE 18 COMPANY RANKING IN THE IMMUNOHISTOCHEMISTRY MARKET, 2019
  • 10.3 MARKET EVALUATION FRAMEWORK
    • TABLE 248 MARKET EVALUATION FRAMEWORK: PRODUCT DEVELOPMENT & LAUNCH-THE MAJOR STRATEGY ADOPTED BY PLAYERS
  • 10.4 COMPETITIVE SCENARIO
    • 10.4.1 KEY PRODUCT LAUNCHES
    • 10.4.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
    • 10.4.3 KEY EXPANSIONS
    • 10.4.4 KEY ACQUISITIONS

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 11.1 OVERVIEW
  • 11.2 GLOBAL IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION MATRIX
    • 11.2.1 STARS
    • 11.2.2 EMERGING LEADERS
    • 11.2.3 PERVASIVE
    • 11.2.4 EMERGING COMPANIES
    • FIGURE 19 GLOBAL IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION MATRIX, 2019
  • 11.3 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)**

    • 11.3.1 F. HOFFMANN-LA ROCHE AG
    • FIGURE 20 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)
    • 11.3.2 DANAHER CORPORATION
    • FIGURE 21 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.3.3 AGILENT TECHNOLOGIES, INC.
    • FIGURE 22 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
    • 11.3.4 MERCK KGAA
    • FIGURE 23 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • 11.3.5 BIO-RAD LABORATORIES, INC.
    • FIGURE 24 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
    • 11.3.6 PHC HOLDINGS CORPORATION
    • 11.3.7 BIO-TECHNE CORPORATION
    • FIGURE 25 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.3.8 ABCAM PLC
    • FIGURE 26 ABCAM COMPANY: COMPANY SNAPSHOT (2019)
    • 11.3.9 BECTON, DICKINSON AND COMPANY
    • FIGURE 27 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
    • 11.3.10 PERKINELMER
    • FIGURE 28 PERKINELMER: COMPANY SNAPSHOT (2019)
    • 11.3.11 CELL SIGNALING TECHNOLOGY, INC.
    • 11.3.12 BIO SB, INC.
    • 11.3.13 MILTENYI BIOTEC
    • 11.3.14 CANDOR BIOSCIENCE GMBH
    • 11.3.15 SAKURA FINETEK JAPAN CO., LTD.
    • 11.3.16 EAGLEBIO
    • 11.3.17 BIOCARE MEDICAL, LLC
    • 11.3.18 ELABSCIENCE, INC.
    • 11.3.19 BIOGENEX
    • 11.3.20 DIAGNOSTIC BIOSYSTEMS

*Details on Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS